| Literature DB >> 18588677 |
André Klussmann1, Hansjuergen Gebhardt, Falk Liebers, Monika A Rieger.
Abstract
BACKGROUND: The aim of this study was to determine the prevalence and the predictors of musculoskeletal symptoms in the upper extremities and neck at visual display terminal (VDT) workstations.Entities:
Mesh:
Year: 2008 PMID: 18588677 PMCID: PMC2474829 DOI: 10.1186/1471-2474-9-96
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Selected international literature regarding symptoms or disorders in employees working at VDT workstations, in chronological order.
| Eltayeb et al. 2007 [ | cross-sectional | 264 computer workers | not indicated (n.i.) | not indicated (n.i.) | - Prevalence of musculoskeletal complaints: neck: 33%, shoulder: 31%, upper arm: 12%, elbow: 6%, lower arm: 8%, wrist: 8%, hand: 11% (complaints during the previous year that lasted at least one week). |
| Ye at al. 2007 [ | cross-sectional | 2,327 VDT users | n.i. | mean: 19.3 days/month | - Age less than 40 years, not receiving breaks during VDT work, and the presence of eyestrain and musculoskeletal pain were significantly associated with poor general health status (high GHQ scores). |
| Thomsen et al. 2007 [ | case-control | 18 cases (VDT-workers with symptoms); 20 controls (VDT-workers without symptoms) | cases: 47.0 h/week controls: 35.5 h/week | cases: 28.6 h/week controls: 23.9 h/week | - Computer users with forearm pain and moderate to severe palpation tenderness had diminished forearm extensor muscle fatigue response. |
| Kubo et al. 2006 [ | cross-sectional | 2,161 office workers | n.i. | n.i. | - Positive relationship between VDT work and sick building syndrome (SBS) in men. |
| Gerr et al. 2005 [ | intervention study (3 years) | 3 intervetion groups | n.i. | n.i. | - No differences in risk of musculoskeletal symptoms were observed among participants randomly assigned to two workstation and postural interventions in comparison to participants who received no workstation or pos-tural intervention. |
| Juul-Kristensen & Jensen 2005 [ | cohort study | 3,361 office workers in 11 Danish companies | n.i. | n.i. | - Working as much as 75% of the work time at the computer increased the probability of musculoskeletal disorders in the neck/shoulder and elbow/hand. |
| Lassen et al. 2004 [ | cohort study | 6,943 technical assistants and machine technicians with VDT | 69.5% full time work | 24.3 h/week | - Detailed examination of self-reported exposures showed that mouse and keyboard-related work time predicted elbow and wrist/hand pain from low exposure levels without a threshold effect. |
| Kryger et al. 2003 [ | cohort study | same sample as in the study of Lassen et al. [ | - Intensive use of a mouse device and (to a lesser extent) keyboard usage, were the main risk factors for forearm pain. | ||
| Sillanpää et al. 2003 [ | cross-sectional | office workers (n = 298), customer service workers (n = 238) and designers (n = 247) | n.i. | total sample < 2 h/day: 2.3%; 2–4 h/day: 15.3%; 4–6 h/day: 23.0% > 6 h/day: 47.4% | - For all the occupations combined, the 12-month prevalence of musculoskeletal symptoms in the neck, shoulders, elbows, lower arms and wrists, and fingers were 63, 24, 18, 35 and 16%, respectively. |
| Gerr et al. 2002 [ | cohort study | 632 individuals with more than 15 h computer work per week. | 38 h/week | mean 28 h/week | - Musculoskeletal symptoms (MSS) and disorders (MSD) in neck/shoulder (N/S) or hand/arm (H/A) were common among computer users. |
| Nakazawa et al. 2002 [ | cohort study | 25,000 office workers | n.i. | 21% < 1 h/day 29% 1–3 h/day 22% 5–5 h/day 28% > 5 h/day | - Physical symptoms became more severe with increased daily VDT use without a threshold value effect. |
| Ariens et al. 2001 [ | cohort study | 1,334 workers from 34 companies | mean: 39.2 h/week | n.i. | - Sitting at work for more than 95% of the working time seems to be a risk factor for neck pain. |
| Bode & Isfort 2001 [ | cross-sectional | 1,002 office workers (VDT ≥ 3 h/day) | n.i. | mean: 5 h/day | 24-month prevalence: induration of the neck and shoulder area: 62%, muscle pain in the arm: 24%, paresthesia in the arm: 16%, paresthesia in the fingers or pain in the hand: 13% and 12% respectively (multiple answers possible). |
| Hartmann & Guetschow 1999 [ | cross-sectional | 205 female office workers | n.i. | n.i. | - Monthly prevalence of symptoms: neck: 40%, shoulders: 36% |
| Ertel et al. 1997 [ | cross-sectional | 352 female office workers | mean: 8.4 h/day | mean: 5.45 h/day | - Prevalence of symptoms during and after work: shoulder & neck: 62.7%, back: 53.0%, head: 45.3% and hands/arms/legs: 24.2%. |
| Michaelis et al. 1997 [ | cross-sectional | 1,720 office workers | n.i. | n.i. | - Point prevalence of musculoskeletal symptoms: 62%. |
| Bergqvist et al. 1995 [ | cross-sectional | 353 office workers | n.i. | n.i. | - No general differences between VDT and non-VDT users as to the occurrence of muscular problems. |
| Schwaninger et al. 1991 [ | cross-sectional | 2,722 office workers in different companies | n.i. | 33% 1/4, 27% 2/4, 27% 3/4, 13% 4/4 of work time | - Prevalence of musculoskeletal symptoms: neck pain: 38%, back pain: 38%, pain in the shoulders: 32%, pain in the arms/hands: 11% (no indication of reference period). |
Figure 1Study participants.
Figure 2Factors with possible influence on symptoms.
Figure 3Characteristics of the evaluated VDT workstations; n = 1,035.
Characteristics of the employees' sample: gender, age, and duration of daily VDT use at various workplaces (> 1 h/d)
| Female | 306 | 38.8 | 10.8 | 5.9 | 2.1 | 28.9 | |
| Male | 497 | 41.5 | 9.0 | 5.4 | 2.1 | 46.9 | |
| Female | 65 | 37.6 | 8.9 | 4.0 | 2.2 | 6.1 | |
| Male | 94 | 39.0 | 9.7 | 3.1 | 1.6 | 8.9 | |
| Female | 5 | 30.6 | 5.6 | 3.5 | 1.0 | 0.5 | |
| Male | 77 | 38.1 | 9.0 | 3.9 | 2.5 | 7.3 | |
| Female | 5 | 28.8 | 9.4 | 3.1 | 2.0 | 0.5 | |
| Male | 11 | 41.4 | 11.2 | 5.2 | 3.8 | 1.0 | |
| Female | 381 | 38.3 | 9.9 | 5.5 | 3.2 | 35.9 | |
| Male | 679 | 40.8 | 9.2 | 4.9 | 2.3 | 64.1 | |
* 5 subjects didn't indicate their age
12-month symptom prevalence (bold font) with 95% confidence interval (95%-CI) and total number of affected employees classified according to age groups. (prev.=prevalence)
| 95%-CI | n | 95%-CI | n | 95%-CI | n | 95%-CI | n | |||||||
| Female, n = 379 | Total female | 61.2, 70.7 | 250 | 40.6, 50.7 | 173 | 11.9, 19.2 | 59 | 20.2, 28.9 | 93 | |||||
| Age group | < 30 | 53.6, 73.7 | 56 | 29.5, 50.0 | 35 | 5.6, 19.4 | 11 | 19.0, 37.8 | 25 | |||||
| 30–39 | 60.6, 77.2 | 82 | 32.3, 50.0 | 49 | 6.6, 18.6 | 15 | 15.9, 31.2 | 28 | ||||||
| 40–49 | 58.4, 76.2 | 72 | 41.0, 59.9 | 54 | 11.3, 26.1 | 20 | 12.9, 28.2 | 22 | ||||||
| 50–59 | 50.6, 74.4 | 40 | 42.5, 66.9 | 35 | 10.4, 30.2 | 13 | 17.1, 39.1 | 18 | ||||||
| Male, n = 678 | Total male | 44.3, 51.9 | 326 | 29.3, 36.3 | 223 | 12.1, 17.5 | 100 | 16.0, 21.8 | 128 | |||||
| Age group | < 30 | 30.5, 52.1 | 33 | 11.2, 28.8 | 16 | 4.4, 18.2 | 9 | 2.6, 15.0 | 7 | |||||
| 30–39 | 42.9, 55.5 | 120 | 24.9, 36.5 | 75 | 7.2, 15.0 | 27 | 15.1, 25.1 | 49 | ||||||
| 40–49 | 42.0, 55.2 | 107 | 30.0, 42.8 | 80 | 11.9, 21.7 | 37 | 14.3, 24.7 | 43 | ||||||
| 50–59 | 42.9, 60.3 | 66 | 32.1, 49.1 | 52 | 13.2, 27.0 | 27 | 15.4, 30.0 | 29 | ||||||
| All n = 1,057 | 51.5, 57.5 | 576 | 34.6, 40.4 | 396 | 12.8, 17.2 | 159 | 18.4, 23.4 | 221 | ||||||
1-week symptom prevalence (bold font) with 95% confidence interval (95%-Cl) and total number of affected employees classified according to age groups. (prev.=prevalence)
| 95%-CI | n | 95%-CI | n | 95%-CI | n | 95%-CI | n | |||||||
| Female, n = 379 | Total female | 23.4, 32.5 | 106 | 15.3, 23.2 | 73 | 2.0, 5.9 | 15 | 5.2, 10.6 | 30 | |||||
| Age group | < 30 | 21.0, 40.3 | 27 | 9.2, 24.9 | 15 | * | 1 | * | 4 | |||||
| 30–39 | 19.7, 35.8 | 33 | 8.7, 21.5 | 18 | * | 4 | * | 9 | ||||||
| 40–49 | 20.4, 37.6 | 31 | 14.5, 30.3 | 24 | * | 7 | 3.8, 14.9 | 10 | ||||||
| 50–59 | 12.8, 33.3 | 15 | 14.1, 35.1 | 16 | * | 3 | * | 7 | ||||||
| Male, n = 678 | Total male | 13.5, 19.0 | 111 | 10.5, 15.5 | 89 | 3.7, 7.1 | 37 | 4.1, 7.6 | 40 | |||||
| Age group | < 30 | 8.2, 24.3 | 13 | * | 7 | * | 1 | * | 2 | |||||
| 30–39 | 8.5, 16.9 | 31 | 6.1, 13.5 | 24 | * | 8 | 2.5, 8.1 | 13 | ||||||
| 40–49 | 8.4, 17.7 | 29 | 8.0, 17.5 | 28 | 2.6, 9.3 | 13 | 2.6, 9.3 | 13 | ||||||
| 50–59 | 20.8, 36.0 | 38 | 15.3, 29.5 | 30 | 5.9, 16.5 | 15 | 4.2, 13.7 | 12 | ||||||
| All n = 1,057 | 18.0, 22.8 | 217 | 13.0, 17.4 | 162 | 3.6, 6.2 | 52 | 5.1, 8.1 | 70 | ||||||
* due to the small prevalence, a 95%-CI could not be calculated [38]
Multivariable analysis of symptom-predicting factors (12-month prevalence) – final model (step 6). The bold font indicates the significant factors.
| p-value | OR | 95%-CI | p-value | OR | 95%-CI | p-value | OR | 95%-CI | p-value | OR | 95%-CI | ||
| Years on the job | 0.255 | 1.008 | 0.994, 1.022 | 0.399 | 1.007 | 0.991, 1.023 | |||||||
| Gender | 0.285 | 1.247 | 0.832, 1.868 | 0.069 | 1.385 | 0.975, 1.967 | |||||||
| Body Mass Index | 0.196 | 1.027 | 0.987, 1.068 | 0.261 | 1.023 | 0.983, 1.064 | 0.303 | 1.024 | 0.979, 1.072 | ||||
| Main work-place | Office | 0.424 | 0.787 | 0.572 | 0.272 | ||||||||
| Laboratory | 0.140 | 1.345 | 0.907, 1.995 | 0.506 | 1.145 | 0.769, 1.704 | 0.167 | 1.438 | 0.860, 2.404 | 0.071 | 1.523 | 0.965, 2.403 | |
| Production/storehouse | 0.823 | 0.942 | 0.559, 1.587 | 0.663 | 1.128 | 0.656, 1.940 | 0.572 | 1.235 | 0.594, 2.566 | 0.679 | 0.861 | 0.423, 1.751 | |
| Other | 0.516 | 1.519 | 0.430, 5.361 | 0.427 | 1.621 | 0.492, 5.337 | 0.768 | 1.245 | 0.289, 5.363 | 0.920 | 1.074 | 0.267, 4.316 | |
| Typing | 0.228 | 1.045 | 0.973, 1.122 | 0.062 | 1.096 | 0.995, 1.207 | 0.276 | 1.048 | 0.964, 1.139 | ||||
| Job rotation | 0.244 | 1.211 | 0.877, 1.673 | 0.997 | 0.999 | 0.641, 1.557 | |||||||
| Job satisfaction | 0.362 | 0.996 | 0.987, 1.005 | 0.392 | 0.995 | 0.985, 1.006 | |||||||
| Chair optimally adjustable | 0.615 | 0.860 | 0.478, 1.548 | 0.481 | 0.810 | 0.451, 1.456 | 0.202 | 0.631 | 0.311, 1.280 | 0.064 | 0.551 | 0.293, 1.036 | |
| Constant | 0.598 | 0.698 | 0.018 | 0.203 | 0.001 | 0.060 | 0.025 | 0.175 | |||||
Figure 4Predictors for the 12-month symptom prevalence – final model: odds ratio with 95% confidence interval.
Characteristics of the subgroup who took the medical examination compared to the total sample
| Neck | Shoulder | Elbow/forearm | Hand/wrist | ||||||
| 1,065 | 684 men | 39.9 ( | 5.1 ( | 40.9 ( | 14.5 | 11.5 | 3.5 | 4.5 | |
| 82 | 45 men | 43.6 ( | 5.8 ( | 40.6 ( | 43.9 | 31.7 | 13.4 | 13.4 | |
Figure 5Diagnoses among the employees who underwent physical examination (n = 82) (multiple answers were possible).
Figure 6Results of workstation evaluation and data of the BiFra database (2000–2005).
Figure 71-week prevalence of symptoms with 95% confidence interval (95%-CI). VDT workers (n = 1,065) (VDT) vs. random sample of German population derived from the German Health Survey (BGS) (extract: 20 to 60 years old, n = 5,208).